Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression

Throughout the years, research into signalling pathways involved in cancer progression has led to many discoveries of which mechanistic target of rapamycin (mTOR) is a key player. mTOR is a master regulator of cell growth control. mTOR is historically known to promote cell growth by enhancing the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Rad, Ellie, Murray, James T., Tee, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789355/
https://www.ncbi.nlm.nih.gov/pubmed/29301334
http://dx.doi.org/10.3390/cancers10010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789355/
https://www.ncbi.nlm.nih.gov/pubmed/29301334
http://dx.doi.org/10.3390/cancers10010005

Ejemplares similares